Piper Jaffray Not Convinced MannKind's Afreeza Will Be Commercial Success
April 02, 2014 at 14:42 PM EDT
On Wednesday, Piper Jaffray raised the price target for MannKind (NASDAQ: MNKD) from $1.50 to $2 and reiterated an Underweight rating ...